BRCA2 and cancer: In the current study, we used a zebrafish model to investigate the impact of BRCA2 mutation on meiotic and mitotic cell cycle outcomes and to assess the relationship between brca2 mutation, ploidy, and survival in cancer-bearing zebrafish.